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Genomic instability is a hallmark of cancer. The WW domain-
containing oxidoreductase (WWOX) is a tumor suppressor spanning
the common chromosomal fragile site FRA16D. Here, we report a
direct role ofWWOX in DNAdamage response (DDR) andDNA repair.
We show that Wwox deficiency results in reduced activation of the
ataxia telangiectasia-mutated (ATM) checkpoint kinase, inefficient
induction and maintenance of γ-H2AX foci, and impaired DNA repair.
Mechanistically, we show that, upon DNA damage, WWOX accumu-
lates in the cell nucleus, where it interacts with ATM and enhances its
activation. Nuclear accumulation of WWOX is regulated by its K63-
linked ubiquitination at lysine residue 274, which is mediated by the
E3 ubiquitin ligase ITCH. These findings identify a novel role for the
tumor suppressor WWOX and show that loss of WWOX expression
may drive genomic instability and provide an advantage for clonal
expansion of neoplastic cells.
genomic instability | common fragile sites | WW domain-containing
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Genomic instability is a common characteristic of humancancers. The DNA damage response (DDR) maintains the
integrity of the genome in response to DNA damage. DDR is
a complex signaling process that results in cell cycle arrest fol-
lowed by either DNA repair or apoptosis if the DNA damage is
too extensive to be repaired (1–3). Key mammalian damage re-
sponse sensors are ataxia telangiectasia-mutated (ATM), ATM
and Rad3-related, and DNA-dependent PKs (4, 5). Disruption
of the DDR machinery in human cells leads to genomic in-
stability and an increased risk of cancer progression (6, 7).
The WW domain-containing oxidoreductase (WWOX) gene
spans the common fragile site (CFS) FRA16D (8, 9). Genomic
alterations affecting the WWOX locus have been reported in
several types of cancer and include homozygous and hemizygous
deletions (10–13). Ectopic expression of WWOX in WWOX-
negative cancer cells attenuates cell growth and suppresses tumor
growth in immunocompromised mice (10, 11, 14). Importantly,
targeted ablation of Wwox in mice results in higher incidence of
spontaneous lesions resembling osteosarcomas and lung and
mammary tumors (14–16). These findings suggest WWOX
as a tumor suppressor. The WWOX protein contains two N-
terminal WW domains mediating WWOX interaction with
PP(proline)x(amino acid)Y(tyrosine)-containing proteins (11,
17) and a central short-chain deyhdrogenase/reductase do-
main that has been proposed to function in steroidogenesis
(18). Recent characterization of WWOX domains revealed
that they interact, mainly through the WW1 domain, with mul-
tiprotein networks (3). The mechanism by which WWOX sup-
presses tumorigenicity is, however, not well-known.
In vitro, CFSs are defined as gaps or breaks on metaphase
chromosomes that occur in cells treated with inhibitors of DNA
replication (19, 20). In vivo, CFSs are preferential targets of
replication stress in preneoplastic lesions (21), and emerging
evidence suggests that they represent early warning sensors for
DNA damage (22–24). Both genetic and epigenetic factors are
thought to regulate the fragility of CFS (25, 26). Recent profiling
studies of CFS provide evidence that the functional fragility of
CFS is tissue-specific (27–29). High-throughput genomic analyses
of 3,131 cancer specimens (12) and 746 cancer cell lines (13) have
recently identified large deletions in CFSs, including the FRA16D/
WWOX locus. Although these deletions have been linked to the
presence of DNA replication stress (30), the molecular function of
gene products of CFSs, including the WWOX protein, is poorly
understood. Here, we identify a direct role of WWOX in the DDR
and show that the WWOX gene product functions as a modulator
of the DNA damage checkpoint kinase ATM.
Results
Induction of WWOX Expression After DNA Damage. To determine
whether WWOX plays a role in DDR, we examined the effect of
induction of DNA double-strand breaks (DSBs) on WWOX
mRNA levels using quantitative RT-PCR. DSBs were generated
by using ionizing radiation or the well-established radiomimetic
drug neocarzinostatin (NCS). Interestingly, 10 min after exposure
of MCF7 cells to ionizing radiation, WWOX mRNA levels in-
creased twofold (Fig. 1A). This increase was transient, andWWOX
mRNA levels returned to baseline at 1–2 h (Fig. 1A). Of note, no
altered expressions of the fragile site gene FHIT and the WWOX
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neighboring gene MAF after induction of DSBs were observed
(Fig. 1A), suggesting that this effect is specific for WWOX.
Furthermore, immunoblot analysis revealed an increase of
WWOX protein levels in response to induction of DSBs in MCF7
cells (Fig. 1 B and C). Of note, a comparable increase of WWOX
protein expression was evident in primary mouse embryonic fi-
broblast (MEF) (Fig. 1 D and E), HEK293 (Fig. S1A), and LM7
cells (Fig. S1B), indicating that WWOX induction is not a cell
line-specific phenomenon. These results indicate that WWOX
protein expression is induced early after DNA damage, suggesting
a potential role of WWOX in the DDR.
WWOX Depletion Decreases Genomic Stability Upon DNA Damage. Be-
cause WWOX is induced by DNA damage, we set out to determine
whether loss of WWOX expression affects genome stability. To this
end, we performed comet assays with WWOX-depleted and control
MCF7 cells and measured the comet tail moment of individual cells,
which provides an indirect measurement of DNA DSBs. In-
terestingly, depletion of WWOX was associated with increased
DSBs after induction of DNA damage (Fig. 2 A and B). These
results suggest that loss of the WWOX gene product results in ge-
nomic instability upon DNA damage.
WWOX Regulates Activation of the ATM Checkpoint. To evaluate the
molecular nature of the defects observed in WWOX-depleted
cells, we examined whether WWOX modulates the ATM signaling
pathway, because ATM checkpoint kinase is the central coordinator
of the DDR upon DSBs (31). After ionizing radiation treatment,
MCF7 cells accumulated the activated Ser1981–phosphorylated-
(p-) ATM. Accordingly, phosphorylation of the ATM substrates
KAP1 and H2AX was evident (Fig. 2C, lanes 1–6). In contrast,
WWOX-depleted MCF7 cells exhibited reduced p-ATM, p-H2AX
(γ-H2AX), and p-KAP1 levels (Fig. 2C, lanes 7–12), suggesting
blunted ATM function. In contrast, overexpression of WWOX but
not WWOX-WFPA (a mutant form of WWOX, in which its WW1
domain has impaired interaction ability) (3, 32) in a WWOX-
negative breast cancer cell line, MDA-MB231, was associated with
improved DDR signaling (Fig. S2A). In addition, we also used
WWOX+/+ (WT), WWOX+/− (HET), andWWOX−/− (KO)MEFs
and analyzed p-KAP1 as an ATM substrate after induction of
DSBs. Strikingly, genetic deletion of WWOX also resulted in
reduced p-KAP1 levels (Fig. S2B), indicating that WWOX also
regulates ATM signaling in nontumorigenic cells.
Next, we reconstituted WWOX expression in WWOX-depleted
MCF7 cells using lentiviral transduction and analyzed the ATM
checkpoint. WWOX-depleted MCF7 cells were transduced with
scramble [Lenti–empty vector (EV)], Lenti-WWOX, or Lenti-
WWOX-WFPA, and stable clones were generated. As expected,
upon induction of DSBs, WWOX-depleted cells showed reduced
p-ATM and p-KAP1 levels (Fig. 2D, lanes 4–6). Of note, re-
constitution of WT WWOX expression (Fig. 2D, lanes 7–9) but
not WWOX-WFPA (Fig. 2D, lanes 10–12) rescued ATM sub-
strate phosphorylation upon DSB induction. Together, these
results indicate that WWOX expression is necessary for proper
ATM checkpoint function and that the WW1 domain of WWOX
plays a critical role in this function.
WWOX Depletion Leads to Impaired γ-H2AX Foci Formation. To fur-
ther examine whether the checkpoint defect in WWOX-depleted
andWwox KOMEFs resulted from impaired checkpoint signaling,
we examined γ-H2AX levels and foci formation (33–35). Consis-
tent with our observations, immunoblotting indicated that WWOX
knockdown in MCF7 cells was associated with attenuated histone
H2AX phosphorylation (Fig. S3A). Confocal microscopy revealed
that γ-H2AX foci formation was clearly delayed in KO MEFs
compared with their WT counterparts (Fig. 3A).
To validate that the delay of γ-H2AX foci formation is caused
by WWOX deficiency, we reconstituted Wwox KO MEFs using
adenoviral transduction to reveal Ad-WWOX and Ad-GFP
control MEFs. Strikingly, reconstitution of WWOX expression in
KO MEFs rescued γ-H2AX foci formation to comparable levels
as in WT cells (Fig. 3B). Together, these findings establish a role
of WWOX in the early steps of the DDR.
To further examine the role of WWOX in DDR, we aimed to
determine the consequences of WWOX depletion at early and
late stages of the DDR. To this end, WWOX-depleted MCF7
cells were treated with ionizing radiation for 15 min, 24 h, and
48 h, and γ-H2AX foci were counted using confocal microscopy
(Fig. 3C). We observed higher numbers of γ-H2AX foci in
MCF7 control cells compared with WWOX-depleted cells at
15 min after NCS treatment (Fig. 3C and Fig. S3B). Intriguingly,
the number of γ-H2AX foci, a well-established surrogate marker
for DSBs, was also higher in WWOX-depleted MCF7 cells an-
alyzed 24 and 48 h after treatment (Fig. 3C and Fig. S3B). Al-
together, these results suggest that WWOX loss also affects
DNA repair.
WWOX Regulates DNA Repair. To address whether WWOX plays
a role in DNA repair, we assessed DNA damage repair ability in
WWOX-manipulated cells. Control or WWOX-depleted MCF7
cells were transfected with a microhomologous DNA damage
repair reporter, pGL2-Luc, which has been linearized with either
HindIII or EcoRI (36). Forty-eight hours posttransfection, the
cells were collected, and luciferase activity was quantified. With
HindIII digestion, no significant difference in Luc activity be-
tween control and WWOX-knockdown MCF7 cells was observed
(Fig. 3D). In contrast, upon EcoRI digestion, control MCF7 cells
were able to recover about 80% of Luc activity, whereas WWOX-
depleted MCF7 cells recovered only 15% (Fig. 3D). Because
EcoRI cuts within the coding sequence of the luciferase gene,
Fig. 1. Induction of WWOX expression early after DNA damage stimuli. (A)
Real-time PCR analysis of WWOX, FHIT, and MAF in MCF7 after ionizing radia-
tion treatment for the indicated time points. (B–E) Immunoblot blot analyses of
WWOX levels in (B and C) MCF7 and (D and E) early-passage MEFs after treat-
ment with ionizing radiation (10 Gy) or NCS (200 ng/mL) for different time
points. Equal loading was confirmed by blotting with α-GAPDH–specific anti-
body. Fold change of WWOX expression upon DNA damage relative to un-
treated cells is shown below each blot.
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restoration of luciferase activity requires precise rejoining of the
short protruding ends, which involves microhomologous DNA
damage repair. Reduced Luc activity in WWOX-depleted MCF7
cells indicates that WWOX is critical for microhomologous DNA
damage repair. Because HindIII cuts within the linker region be-
tween the SV40 promoter and the Luc coding sequence, restoration
of luciferase activity does not require precise end joining (36).
To further examine the role of WWOX in homologous re-
combination (HR), we used an I-SceI–dependent GFP reporter
assay to measure HR in WWOX-expressing U2OS cells. This
assay depends on reconstitution of GFP expression in conse-
quence of repair of an induced I-SceI–induced DSB (37). We
generated a stable U2OS-DR-GFP–expressing WWOX or con-
trol vector cells (Fig. S3C). Cells were transfected with I-SceI
and harvested 48 h later, and the number of GFP-positive cells
was assessed. The GFP-positive population increased approxi-
mately twofold from 10% to 21% after I-SceI expression in the
cells expressing WWOX (Fig. 3E), suggesting a more efficient
HR repair in the cells containing WWOX. In accordance,
WWOX-WFPA or WWOX-K274R (see below) expression was
not associated with improved HR (Fig. 3E). Taken together,
these results suggest that WWOX affect DNA repair.
WWOX Physically Associates with ATM. We next investigated the
molecular mechanism by which WWOX contributes to the
DDR and ATM checkpoint function. The observed defects in
ATM activation and ATM substrate phosphorylation, in-
cluding H2AX and KAP1 , prompted us to investigate po-
tential physical interaction between WWOX and ATM. To
this end, MCF7 cells were treated with NCS, and endogenous
WWOX was immunoprecipitated from cell lysates with anti-
WWOX antibody and analyzed by immunoblotting. Anti-IgG
immunoprecipitation was used as the negative control. Strik-
ingly, endogenous p-ATM and p-KAP1 specifically coimmu-
noprecipitated with WWOX after induction of DSBs,
suggesting that both proteins interact after DNA damage (Fig.
4A). Comparable results were obtained in ionizing radiation-
treated HEK293 cells ectopically expressing Myc-WWOX (Fig.
Fig. 2. Depletion of WWOX renders cells more susceptible to DSBs and compromises DNA damage-induced ATM checkpoint activation. (A) Comet assay.
Control- (EV-Sh) and WWOX-depleted MCF7 (WWOX-Sh) cells were treated or not treated with NCS (200 ng/mL) for 1 h. Single cells were then electro-
phoresed in agarose gel on a slide and stained with SyberGreen. Labeled DNA was visualized under a fluorescence microscope using 60× magnification.
Representative images are shown. (B) Quantification of the comet assay in A. Bars show the comet tail as measured using ImageJ 1.47g software. Results show
that MCF7-sh (WWOX-depleted) treated with NCS accumulates more DSBs relative to EV-control cells. (C) Control- and WWOX-depleted MCF7 cells were
untreated or treated with ionizing radiation (10 Gy). Whole-cell lysates were prepared at the indicated time points, and immunoblot analysis was performed
using specific antibodies against ATM, p-ATM (Ser1981), KAP1, p-KAP1 (pThr824), total H2A.X, γ-H2AX (pSer139), WWOX, and GAPDH. (D) WWOX-depleted
MCF7 cells (MCF7-sh) were transduced with lentiviral vectors expressing scramble (EV), WT WWOX, or WT WWOX-WFPA mutant and selected with neomycin.
The different cells were untreated or treated with NCS (200 ng/mL) for the indicated time points. Whole-cell lysates were prepared at the indicated time
points, and immunoblot analysis was performed using specific antibodies against ATM, p-ATM, KAP1, p-KAP1, WWOX, and GAPDH. IR, ionizing radiation.
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4B). These data indicate that WWOX forms a complex with
ATM in response to DNA damage.
To map the WWOX–ATM interaction modules, HEK293 cells
were transfected with a truncated form of GST-WWOX expressing
intact or mutant WWOX, DSBs were induced, and GST pull-down
assays were performed. ATM coprecipitated with the intact WW1
domain but not mutant GST-WW1-WFPA, GST-WW2, or GST-
SDR, indicating that the WW1 domain of WWOX mediates the
interaction of WWOX with ATM (Fig. S4A). To map the inter-
action interface on ATM, we synthesized truncated ATM proteins
using in vitro translation and incubated them with bacterial purified
GST-WWOX. The results suggest that WWOX interacts with the
region spanning amino acids 1,530–2,100 (Fig. S4B). Together,
these data indicate that WWOX physically interacts with the
checkpoint kinase ATM.
WWOX Modulates ATM Activity. Our findings so far suggest that
WWOX interacts with ATM (Fig. 4 A and B), hence facilitating
ATM proper kinase function (Figs. 2 and 3). These results prompted
us to examine whether, in WWOX-deficient cells, ATM and other
DDR proteins are properly recruited to DNA damage foci. Indeed,
WWOX KO MEFs display reduced p-ATM recruitment to DNA
damage foci upon ionizing radiation treatment compared with WT
MEFs (Fig. 4C). Interestingly, the intensity of γ-H2AX is higher in
KO cells, consistent with impaired DNA repair as in previous
observations (Fig. 3C). Additionally, MCF7-shWWOX cells dis-
played reduced MDC1 and p-CHK2 recruitment to DNA damage
foci (Fig. S5), which is consistent with impaired ATM function.
To analyze the molecular mechanisms by which WWOX affects
ATM activation, we examined the effect of WWOX expression on
ATMmonomerization. ATM exists in vivo as an inactive dimer that
Fig. 3. Impaired γ-H2AX signals and DNA repair in WWOX-manipulated cells after DNA damage. (A) WT or KO MEFs were untreated or treated with
ionizing radiation (10 Gy) and fixed at the indicated time points, and immunofluorescence analysis for γ-H2AX (red) was carried out. DAPI staining was
performed to indicate the positions of nuclei. Cells were examined by confocal microscopy under 60×magnification. Close-up views of one cell are shown in
column 5 (zoom = 5×). Quantification of γ-H2AX foci is shown under the panels as the average foci number per cell ± SEM; P < 0.002 in treatment of 30 min
between WT and KO MEFs. (B) KO and WT MEFs were transduced with Ad-WWOX or Ad-GFP, treated with ionizing radiation (10 Gy), and fixed after
15 min, and immunofluorescence analysis for γ-H2AX (red) was carried out. A representative experiment is shown. Quantification of γ-H2AX foci is shown on the
right side as the average foci number per cell ± SEM (P = 0.155 comparing KO-AdWWOX with WT-AdGFP; P = 0.118 comparing KO-AdWWOX with WT-
AdWWOX). (C) Quantification of γ-H2AX foci in MCF7 control or WWOX-depleted cells after treatment with ionizing radiation (5 Gy) for different times.
Representative figures are shown in Fig. S3B. The average of γ-H2AX foci in 10 fields is shown in the different treatments. UNT, untreated. (D and E) WWOX
is important for HR. (D) WWOX-depleted MCF7 cells exhibit impaired micro-HR as revealed in cells transfected with pGL2-Luc vector that was linearized with
either HindIII or EcoRI. Luciferase activity after EcoRI treatment was normalized to that of HindIII. (E) U2OS-DR-GFP cells were transduced with indicated
Lenti-WWOX constructs (WWOX, WWOX-WFPA, or WWOX-K274R) (Fig. S3C). The newly generated cells were then transfected with I-SecI. Forty-eight hours
later, cells were harvested and subjected to flow cytometric analysis to analyze the HR efficiency. The percentage of GFP-positive cells is shown. Data
represent averages from three independent experiments.
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dissociates into active monomers after DNA damage (38). To study
ATM activation (monomerization), HEK293T control and
WWOX-depleted cells expressing Flag-tagged ATM and YFP-
tagged ATM were treated with NCS, and the ATM dimer was
analyzed by immunoprecipitation using anti-Flag antibodies fol-
lowed by immunoblotting with anti-YFP antibodies. As expected,
NCS treatment was associated with reduced coimmunoprecipitation
(dimerization) between Flag-ATM and YFP-ATM in HEK293-Sh-
EV cells (Fig. 4D, lane 3 vs. lane 2), indicating proper activation
(monomerization) of ATM. In contrast, WWOX-depleted cells
(HEK293-Sh-WWOX) showed virtually no change in ATM dimer
levels in response to NCS treatment (Fig. 4D, lane 6 vs. lane 5),
suggesting impaired monomerization (activation) of ATM. Fur-
thermore, consistent with impaired ATM activation, immunoblot-
ting revealed reduced p-ATM and p-KAP1 levels in the WWOX-
depleted cells. These findings further confirm our results showing
inefficient ATM activation in WWOX-deficient cells after DNA
damage and suggest a role of WWOX in ATM activation. Taken
together, our results indicate that WWOX interacts with ATM and
modulates its activation.
DNA Damage Triggers Nuclear Accumulation and Ubiquitination of
WWOX. WWOX has been reported to preferentially localize to
the cytoplasm (39–41). Because WWOX binds ATM after DNA
damage and ATM shows mainly nuclear distribution after DNA
damage, we determined whether WWOX might accumulate in the
nucleus in response to DNA damage. Indeed, confocal microscopy
revealed time-dependent accumulation of GFP-WWOX in
the cell nucleus after DSB induction (Fig. S6A).
To confirm the subcellular localization of WWOX, nuclear and
cytoplasmic fractions were purified from damaged and un-
damaged MCF7 cells and analyzed for WWOX expression.
Fig. 4. WWOX association with ATM. (A and B) WWOX–ATM physical association. (A) MCF7 cells were untreated or treated with NCS (200 ng/mL) for 1 h.
Lysates were immunoprecipitated with anti-WWOX mAb. Anti-IgG was used as the negative control. The immunoprecipitates were analyzed by immuno-
blotting using antibodies against p-ATM, p-KAP1, and WWOX. (B) HEK293 cells were transfected with Myc-WWOX expression vector. Twenty-four hours later,
cells were irradiated (10 Gy), and 30 min later, cells were lysed. Lysates were immunoprecipitated with anti-Myc antibody and blotted with anti–p-ATM, anti–
p-KAP1, and Myc (WWOX). (C and D) WWOX–ATM functional association. (C) MEF-WT and MEF-KO cells were treated with ionizing radiation (10 Gy), and 2 h
later, cells were fixed and stained for p-ATM (green) and p-H2AX (red). Nuclei were counterstained with DAPI (blue). Cells were visualized with confocal
microscopy under 60× magnification. (D) WWOX depletion is associated with reduced ATM monomerization. HEK293-Sh-EV and HEK293-Sh-WWOX cells
were cotransfected with Flag-ATM and YFP-ATM. At 48 h, cells were untreated or treated with NCS (200 ng/mL) for an additional 1 h. Whole-cell lysates were
prepared and precleared with mouse anti-IgG followed by immunoprecipitation with anti-IgG (as negative control; lanes 1 and 4) or anti-Flag antibody
overnight at 4 °C. Complexes were then washed, separated on SDS/PAGE, and analyzed by immunoblotting using antibodies against FLAG (self-immuno-
precipitation) and YFP (coimmunoprecipitation). (Left) Whole-cell lysates were analyzed by immunoblotting using the indicated antibodies. GAPDH was used
for normalization. IP, immunoprecipitation.
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Subcellular fractionation was confirmed using HSP90 and Lamin
expressions in the cytoplasmic and nuclear fractions, respectively.
Upon DNA damage, as expected, general WWOX accumulation
was observed. Interestingly, WWOX showed a pronounced ac-
cumulation in the nuclear fraction (Fig. 5A). Furthermore, im-
munoblotting indicated an additional higher molecular weight
WWOX isoform in the nucleus (Fig. 5A), pointing to a specific
posttranslational modification.
We recently reported that WWOX is the target of K63-linked
polyubiquitination by the ubiquitin E3 ligase ITCH, which
translocates WWOX to the nucleus (3). Thus, we tested whether
the increased molecular weight is caused by WWOX ubiquiti-
nation. To this end, HEK293 cells expressing HA-Ubiquitin
(HA-Ub), GST-WWOX, or GST-WWOX-WFPA were left un-
treated or treated with NCS to induce DSBs. GST pull down
revealed that the higher molecular weight WWOX isoform is
enriched and that WWOX, but not WWOX-WFPA, is modified
by ubiquitin after DNA damage (Fig. S6B). In addition, treat-
ment with UVC, a weaker inducer of DSBs, also enhanced
WWOX polyubiquitination (Fig. S6B). To determine the Ub
linkage of WWOX after DNA damage, HEK293 cells expressing
GST-WWOX and HA-Ub, HA-Ub-K63 only, or HA-Ub-K48
only (ubiquitin mutants that are either K63 only or K48 only,
whereas all other lysine residues are mutated to arginine) were
treated with NCS, and lysates were subjected to GST pull down
and immunoblotting analysis. The results indicate that WWOX
undergoes specifically K63-linked polyubiquitination (Fig. S6C).
To determine whether WWOX ubiquitination is associated with
nuclear WWOX, we performed subcellular fractionations. Nu-
clear GST-WWOX, but not WWOX-WFPA, was found to be
polyubiquitinated (Fig. 5B). We also detected WWOX poly-
ubiquitination in the cytoplasmic fraction, presumably because of
the overexpression settings (Fig. 5B). Importantly, ATM activation
(p-ATM) was reduced upon WWOX-WFPA expression com-
pared with WT WWOX. Together, these data suggest that, after
DNA damage, WWOX undergoes K63-linked polyubiquitination,
facilitating its nuclear translocation.
WWOX Is Ubiquitinated at Lysine 274 on DNA Damage. Our recent
data revealed that ITCH mediates WWOX ubiquitination at
K274 (3). To determine whether this lysine residue is critical for
WWOX ubiquitination on DNA damage, we performed site-di-
rected mutagenesis by replacing K274 by arginine (K274R) and
examined ubiquitination after DNA damage. Indeed, K274R
mutant WWOX lacked DNA damage-induced ubiquitination
(Fig. 6A), identifying K274 as a main ubiquitin acceptor lysine
residue on DSBs. Remarkably, expression of WWOX-K274R was
associated with reduced activation of p-ATM (Fig. 6A, Upper),
and reconstitution with WWOX-K274R in WWOX-depleted
MCF7 cells failed to restore KAP1 activation (Fig. S7A), which is
in contrast to WT WWOX (Fig. 2D). We next reasoned that the
K274R mutant should be less stable compared with WTWWOX.
To examine this assumption, we assessed the half-lives of WWOX
and WWOX-K274R after treatment with cyclohexamide and in-
duction of DSBs. We found, indeed, that half-life of WWOX-
K274R is shorter compared with WWOX (Fig. S7B).
Based on these results, we hypothesized that WWOX ubiq-
uitination and stabilization might target it to the nucleus, where
it interacts with ATM. To examine this possibility, we expressed
GST-WWOX or GST-WWOX-K274R in HeLa cells, treated the
cells with NCS, and analyzed WWOX localization by immu-
nostaining. Untreated cells exclusively showed diffuse cytoplas-
mic WWOX staining (Fig. 6B, Upper). NCS treatment led to
significant increased staining of γ-H2AX in cells expressing WT
WWOX but not in WWOX-K274R–expressing cells. In addition,
nuclear staining was significantly higher in cells expressing WT
WWOX compared with WWOX-K274R (Fig. 6B).
We next sought to examine whether forcing WWOX-K274R to
the nucleus is sufficient for ATM interaction and activation.
Therefore, we fused WWOX and WWOX-K274R to a strong nu-
clear localization sequence to reveal WWOX-Nuc and WWOX-
K274R-Nuc isoforms, respectively. Next, we determined their
ubiquitination and ATM-activating functions. Remarkably, our
results indicate that K274 is essential for not only ubiquitination of
WWOX but also, interaction and activation of ATM (Fig. S7C).
Ub E3 Ligase ITCH Ubiquitinates WWOX After DNA Damage. Next, we
aimed to identify the Ub E3 ligase that mediates WWOX
ubiquitination on DNA damage. Our recent work has identified
ITCH as an E3 ligase that associates and mediates K63-linked
polyubiquitination of WWOX, leading to its stabilization and
nuclear translocation (3). However, the physiological context
Fig. 5. WWOX nuclear accumulation and ubiquitination. (A) MCF7 cells were
untreated or treated with NCS (200 ng/mL). At 24 h after NCS treatment, the
cells were fractionated into cytosolic and nuclear extracts. The fractionated
cytosol and nuclear extracts were immunoblotted using antibodies against
WWOX, HSP90, or Lamin. (B) WWOX ubiquitination after DNA damage.
HEK293 cells transfected with HA-Ub and pEBG-WWOX or pEBG-WWOX-WFPA
plasmids. At 24 h, cells were treated with NCS (200 ng/mL) for an additional 1 h.
Cells were then subfractionated into nuclear and cytoplasmic fractions, and GST
pull down was performed. Lysates were blotted against ATM, p-ATM, GST
(WWOX), Lamin (nuclear fraction), GAPDH (cytoplasmic fraction), and anti-HA
(Ub) antibodies. Arrows indicate ubiquitinated WWOX.
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promoting this functional association remained unclear. These
results prompted us to test whether ITCH ubiquitinates WWOX
on DNA damage. Indeed, ectopic expression of ITCH but not
a catalytic mutant mediated WWOX ubiquitination (Fig. 7A,
lane 3 vs. lane 5). This effect was further enhanced after NCS
treatment (Fig. 7A, lane 4). In addition, WWOX physically as-
sociated with ITCH under these conditions (Fig. 7A, Bottom),
which is consistent with our recent observations (3).
Intriguingly, it has been recently suggested that ATM activates
ITCH ubiquitin ligase activity (42). We, therefore, questioned
whether ATM is required for WWOX ubiquitination. Indeed,
we found that treatment with an ATM inhibitor (KU55933),
attenuated WWOX-ITCH interaction and consequently, WWOX
ubiquitination (Fig. 7A, lane 7). These results suggest that ATM
activity is necessary to activate ITCH catalytic function.
To examine whether ITCH is required for WWOX ubiquiti-
nation after DNA damage, we analyzed the effect of ITCH de-
pletion on WWOX ubiquitination. Remarkably, ITCH depletion
resulted in decrease WWOX ubiquitination upon DNA damage
(Fig. 7B).
In addition, we also used Itch-deficient and -proficient MEFs
and determined the effect on the DDR. Our results revealed that
Itch-KO cells display reduced p-KAP1 activation as well as re-
duced WWOX accumulation (Fig. 7C). Together, these results
indicate an important role of ITCH in WWOX regulation on
DNA damage.
Discussion
Targeted deletion of the Wwox gene in mice has previously
shown that WWOX is a bona fide tumor suppressor (15, 16, 43).
However, the molecular mechanism by which loss of WWOX
facilitates tumorogenesis is poorly understood. In this study, we
have identified an unforeseen direct function of WWOX in the
DDR. Our results show that loss of WWOX results in delayed
activation of the DNA damage checkpoint kinase ATM and im-
paired DNA repair. After DNA damage, ATM positively regu-
lates the ligase activity of ITCH (42), which facilitates WWOX
ubiquitination at Lys274 and thereby, promotes translocation of
WWOX into the nucleus. Nuclear WWOX physically interacts
with ATM and facilitates ATMmonomerization and activation in
a positive feed-forward loop manner (Fig. 7D). Although the
detailed mechanism by which WWOX facilitates ATM activation
remains to be elucidated, these findings argue for a direct func-
tion of WWOX in modulating DNA damage signaling.
Conflicting results were reported on WWOX expression upon
exposure to DNA damage. In some reports, WWOX expression
was down-regulated after ultraviolet (UV) exposure (44, 45) but not
affected upon ionizing radiation (45). In contrast, Lai et al. (46)
showed that WWOX levels are up-regulated upon UVB and that
this induction is essential for UVB-induced apoptosis. It remained
unknown whether these treatments induce genomic aberrations at
the FRAD16 locus and/or loss of WWOX expression. It is possible
that breaks in FRA16D, mostly affecting intron 8 in WWOX (9, 18,
47), do not affect WWOX transcription early after DNA damage.
Fig. 6. Ubiquitination of WWOX at Lys274 after DNA damage. (A) HEK293 cells were transfected with HA-Ub and GST-WWOX or GST-WWOX-K274R
plasmids. At 24 h, cells were treated with NCS (200 ng/mL) for an additional 1 h. Cell lysates were blotted against p-ATM, GST (WWOX), and GAPDH.
Pulled down complexes were blotted with anti-HA (Ub), anti-GST (WWOX), and anti–p-ATM antibodies. (B) HeLa cells were transfected with HA-Ub and
GST-WWOX or GST-WWOX-K274R plasmids. At 24 h, cells were treated with NCS (200 ng/mL) for 15 min. Immunostaining was performed using anti-GST
(red) and anti–p-H2AX (green). GST is also observed in control untreated cells, likely because anti-GST stains endogenous GST. DAPI was used as a marker
for nuclei. Cells were examined by confocal microscopy under 60× magnification. Quantification of γ-H2AX foci is shown on the right side as the average
foci number per cell ± SEM (P < 0.001).
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Although WWOX mRNA is up-regulated after DSBs, our findings
show that posttranslational modification of the WWOX protein
seems to be the predominant cause of WWOX accumulation.
Our results show that WWOX functions as an adaptor protein
and is important for proper ATM activation upon DNA damage.
Accordingly, WWOX depletion (hemizygous mutation) or loss
(homozygous mutation) might result in reduced activation of ATM
and substrate phosphorylation, including H2AX, CHK2, and KAP1.
Furthermore, WWOX KO MEFs and WWOX-depleted MCF7
cells exhibited clear defects in p-ATM, γ-H2AX, MDC1, and
p-CHK2 recruitment to DNA damage sites (38, 48). After longer
time periods of DNA damage induction, these cells exhibited in-
creased DSB numbers. These results are consistent with our
finding that WWOX plays a role in DNA repair, suppression of
genomic instability, and impaired activation of ATM. WWOX
has also been shown to be essential for binding and stabilizing
Ser46–p-p53, hence contributing to p53-mediated apoptosis (49)
as well as enhancing p73 proapoptotic function (39). Intriguingly,
the effects of WWOX on DDR signaling seem to be independent
of p53, because the same consequences were observed in p53 WT
(MCF7) and mutant (MDA-MB231) cells. Altogether, these re-
sults further indicate an essential role of WWOX in the DDR.
Our findings suggest that both the WWOX WW1 domain and
K274 ubiquitination are important for ATM interaction and
ATM activation. Interestingly, ITCH interacts with the WW1
domain of WWOX and mediates K63-linked polyubiquitination
at Lys274, highlighting the significance of ITCH in the WWOX
role in DDR. In fact, our results show that ITCH knockdown or
genetic KO is associated with reduced WWOX ubiquitination
and stabilization and thus, impaired DDR. ITCH ubiquitinates
and regulates the stability of several substrates, including p73
(50), p63 (51), Gli (52), and others (53); therefore, we cannot
exclude that other proteins could also contribute to its observed
role in DDR. Although ITCH has been shown to function as
a prosurvival factor (54), our results suggest that it can also
contribute to other functions important for the neoplastic pro-
cess. Future work shall be required to further delineate ITCH
function in DDR and its role in tumorogenesis.
Our data show that the product of the WWOX fragile gene is
directly involved in the DDR through regulating ATM check-
point signaling and maintaining genomic stability. Similar results
highlight the contribution of the FHIT gene, which encompasses
FRA3B and encodes a 14-kDa protein with tumor suppressor
functions (55). Deficiency of the FHIT gene as early as in pre-
neoplastic lesions induced global genome instability and clonal
expansion (56, 57). Likewise, the product of FRA15A (RORA)
and FRA8I (SPIDR), which is inactivated in multiple tumors, has
been shown to be involved in cellular stress response, DNA
damage repair, and maintenance of chromosomal integrity (58,
59), suggesting that their impaired activity may contribute to
genomic instability in cancer cells. These observations suggest
that at least some products of CFSs might play a role in the
DDR. Thus, one may speculate that they function as part of
a highly conserved stress response network that is uniquely sus-
ceptible to genomic instability in cancer cells. Additional work
will be required to decipher the exact function of other CFS gene
products in cellular stress responses.
Our findings support the hypothesis that loss of WWOX provides
a selective advantage in neoplastic transformation, because Wwox-
deficient cells may preferentially acquire additional cancer-pro-
moting mutations caused by an impaired DDR. In fact, Ras-
mediated transformation ofWwox-KOMEFs results in an increased
number of tumorigenic cells compared with WT cells, suggesting
that WWOX deficiency facilitates transformation (60). Deletion or
attenuation of WWOX is observed in early preneoplastic breast
lesions (61, 62) and targeted ablation of murine Wwox-associated
mammary tumor formation (16). It is, thus, likely that loss of
WWOX at early stages of neoplasia acts as a driver of the trans-
formation process through compromising genome stability.
Materials and Methods
Cell Culture and Transient Transfection. HEK293, HeLa, LM7, MDA-MB231,
and MEF cells were grown in DMEM, whereas MCF7 and U2OS cells were
grown in RPMI. Both media were supplemented with 10% (vol/vol) FBS
(Gibco), glutamine, and penicillin/streptomycin (Beit-Haemek). Cells were
routinely authenticated, and cell aliquots from early passages were used.
Transient transfections were achieved using Mirus TransLTi (Mirus Bio LLC)
according to the manufacturer.
RNA Extraction, RT-PCR, and Real-Time PCR. Total RNA was prepared using TRI
reagent (Sigma Aldrich) as described by the manufacturer. One microgram
RNA was used for cDNA synthesis using the First-Strand cDNA Synthesis Kit
Fig. 7. ITCH ubiquitinates WWOX upon DNA damage. (A) HEK293 cells were
transfected with HA-Ub, GST-WWOX, and FLAG-ITCH or FLAG-ITCHC830A
plasmids. At 24 h, cells were mock or KU55933 treated overnight followed by
NCS (200 ng/mL) treatment of 1 h. Cell lysates were blotted against the in-
dicated antibodies. Pulled down complexes were blotted with anti-HA (Ub),
anti-GST (WWOX), and anti-ITCH antibodies. (B) Control- and ITCH-depleted
HEK293 cells were transfected with GST-WWOX and HA-Ub. At 24 h, cells
were incubated with NCS (200 ng/mL) for an additional 1 h. Cell lysates and
pulled down complexes were treated as in A. (C) Itch-KO and WT MEFs were
treated with NCS (200 ng/mL) for the indicated times. Lysates were blotted
using the indicated antibodies. (D) Hypothetical model of WWOX action in
DDR. WWOX deficiency leads to an increased number of DNA strand breaks
after DNA damage. After DNA damage, ATM positively enhances ITCH-
mediated ubiquitination and translocation ofWWOX into the nucleus. Nuclear
WWOX physically interacts with ATM and mediates ATM monomerization
and activation in a positive feed-forward loop manner. When WWOX is lost,
ATM function is hampered.
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(Bio-Rad). Quantitative real-time PCR was performed using Power SYBR
Green PCR Master Mix (Applied Biosystems). All measurements were per-
formed in triplicate and standardized to the levels of GAPDH.
Comet Assay. Comet assay was performed according to the manufacturer’s
instructions (Trevigen Inc.). In brief, MCF7 and WWOX-depleted MCF7 cells
were treated with NCS for 1 h, and then, cells were analyzed for DNA breaks
by assessing the comet tail moment (product of tail length and relative tail
content of DNA).
Cellular Fractionation. Nuclear and cytoplasmic extracts were prepared as
follows. First, cells were scraped in PBS, and after centrifugation, the cell
pellet was reconstituted in a hypotonic lysis buffer (10 mmol/L Hepes, pH 7.9,
10 mmol/L KCl, 0.1 mmol/L EDTA) supplemented with 1 mmol/L DTT and
a broad spectrum mixture of protease inhibitors (Sigma-Aldrich). The cells
were allowed to swell on ice for 15 min; then, 0.5% Nonidet P-40 was added,
and cells were lysed by vortex. After centrifugation, the cytoplasmic fraction
was collected. Afterward, nuclear extracts were obtained by incubating
nuclei in a hypertonic nuclear extraction buffer (20 mmol/L Hepes, pH 7.9,
0.42 mol/L KCl, 1 mmol/L EDTA) supplemented with 1 mmol/L DTT for 15 min
at 4 °C. The nuclear fraction was collected after centrifugation.
Micro-HR Assay. MCF7 cells were transfected with a microhomologous DNA
damage repair reporter, pGL2-Luc vector, linearized with either HindIII or EcoRI.
Forty-eight hours posttransfection, the cells were collected, and luciferase activity
was quantified. Because EcoRI cuts within the coding sequence of the luciferase
gene, the restoration of luciferase activity, therefore, requires the precise
rejoining of the short protruding ends, which involves microhomologous DNA
damage repair. However, because HindIII cuts within the linker region between
the SV40 promoter and the Luc coding sequence, the restoration of luciferase
activity does not require precise end joining. Luciferase activity after the cut with
HindIII was used for normalization.
HR Assay. The assay was established and modified by Weinstock et al. (37).
U2OS cells stabilized with a single copy of DR-GFP were transduced with
EV or Lenti-WWOX constructs. Stable clones were generated after G418
selection. Cells were transfected with I-SecI plasmid. Cells were har-
vested 2 or 3 d after infection and subjected to flow cytometric analysis.
The GFP-positive cell population was measured.
Immunofluorescence. Cells were seeded on round slide coverslips in 12-well
plates. Twenty-four hours later, cells were transfected with the indicated
expression plasmids. Twenty-four hours posttransfection, cells were treated
with a specific DNA damaging agent for a specific time point; then, cells were
fixed in 3.7% PBS-buffered formaldehyde and permeabilized with 0.05%
Triton X-100 at room temperature. Cells were then incubated for 1 h in 10%
goat serum (Invitrogen), primary antibody for 1 h, and secondary antibody for
30 min. Cells were examined by confocal microscopy (Olympus) under 60×
magnification.
GST Pull Down.
Mammalian. HEK293 cells were transfected with expression vectors encoding
mammalian GST-WWOX (pEBG-WWOX), GST-WWOX-WFPA [where trypto-
phan (W44) and proline (P47) in the first WW domain of WWOX were
replaced by phenylalanine (F) and alanine (A), respectively], or GST-WWOX-
K274R [where lysine (K274) was replaced by arginine (R)]. Twenty-four hours
later, cells were exposed to DNA damage and then lysed using 0.5% Nonidet
P-40–containing buffer. After washing, cells were incubated with GST beads
(Amersham) for 4 h at 4 °C, washed, and then, prepared for electrophoresis.
Bacterial. Escherichia coli BL21 (DE3) was transformed with pGEX6.1-WWOX.
After 4 h of induction with 1 mM isopropyl β-D-1-thiogalactopyranoside at
37 °C, bacteria were harvested. GST and GST-WWOX were purified with Fast
Flow Glutathione-Sepharose (GE Healthcare) according to the manu-
facturer’s protocol. Then, bead-bound proteins were equilibrated in buffer
of 20 mM Tris·Cl (pH 7.9), 5 mM MgCl2, 0.1 mM EDTA, 0.5 mM EGTA, 10%
Glycerol, 250 mM KCl, and 0.2% Nonidet P-40 (AM250 buffer).
ATM deletion constructs were in vitro-transcribed and translated, in-
cluding 35S-Methionine, according to the manufacturer’s protocol (TNT
Coupled Reticulocyte Lysate System; Promega). TNT lysates and bead-bound
GST-fusion proteins were incubated in AM250 buffer for 1 h at 4 °C and
subsequently washed four times with AM250. Finally, the beads were boiled
in 1× Laemmli buffer.
Statistical Analysis. Results were expressed as means ± SDs. Student t test was
used to compare values of test and control samples. P < 0.05 indicated
significant difference.
Additional laboratory reagents used are described in SI Materials
and Methods.
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